Cardiac Rehabilitation Market By Program Type (Phase I, Phase II, Phase III), By Therapy Type (Exercise Training, Nutritional Counseling, Psychological Interventions, Risk Factor Modification, Patient Education & Lifestyle Management, Occupational Therapy), By Equipment Used (Treadmills, Elliptical Trainers, Rowing Machines, Stationary Bicycles, Heart Rate Monitors, Blood Pressure Monitors, Wearable Devices & Remote Monitoring Tools, Telemetry & ECG Devices), By Indication (Myocardial Infarction, Coronary Artery Disease (CAD), Heart Failure, Angina, Cardiomyopathy, Coronary Artery Bypass Grafting (CABG), Heart Valve Surgery, Heart Transplantation, Others), By Delivery Model (Center-based Programs, Home-based Programs, Tele-rehabilitation Programs, Hybrid Models), and By End User (Hospitals & Cardiac Specialty Centers, Ambulatory Surgical Centers (ASCs), Rehabilitation Centers, Homecare Settings, Fitness & Wellness Centers), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape Cardiac Rehabilitation Market in the coming years?

The Cardiac Rehabilitation Market accounted for USD 2.67 Billion in 2024 and USD 2.83 Billion in 2025 is expected to reach USD 5.12 Billion by 2035, growing at a CAGR of around 6.1% between 2025 and 2035. The cardiac rehabilitation market is the industry that revolves around programmes and services that aim at enhancing the health and recovery of individuals with heart conditions, particularly following such events as heart attack, heart surgery, or heart failure. Such programmes usually incorporate exercise, learning about healthy living of the heart, and stress-reduction counselling. It has hospitals, outpatient rehab centres, and home-based care in the market, backed by an increasing demand because of increased rates of cardiovascular diseases in the world. This sector is also being influenced by technological developments that include remote monitoring and mobile health applications. The further contribution to its growth is increasing awareness and positive healthcare policies.

What do industry experts say about the Cardiac Rehabilitation market trends?

"Cardiac rehabilitation is one of the most effective yet underutilized therapies we have in cardiovascular medicine. It not only improves survival but also enhances quality of life and reduces hospital readmissions."

• Dr. Randal Thomas, MD, MSc, Professor of Medicine, Mayo Clinic, Rochester; Former President, American Association of Cardiovascular and Pulmonary Rehabilitation (AACVPR)

"Participation in cardiac rehabilitation cuts mortality risk by about 25% and rehospitalization by 30%. Expanding access through home-based and hybrid models is essential for reaching more patients worldwide."

• Dr. Sherry L. Grace, PhD, Professor, York University (Toronto); Director of Cardiac Rehabilitation Research, University Health Network, Canada

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Cardiac Rehabilitation market?

Does increasing cardiovascular disease incidence escalate cardiac rehabilitation demand?

The rising incidence of cardiovascular disease (CVD) is a direct increase in cardiac rehabilitation (CR) services. The World Health Organisation (WHO) states that CVDs are the number one cause of mortality in the world, with them taking around 17.9 million lives every year. In India, the Ministry of Health and Family Welfare documented a significant increase in the death rates related to CVD, especially ischaemic heart disease, which by itself resulted in 28.1% of all deaths in 2020. This increased disease burden has necessitated the increased focus on secondary prevention strategies such as CR.

Further, the National Programme on Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases and Stroke (NPCDCS) has increased infrastructure by setting up hundreds of Cardiac Care Units (CCUs) in districts. Such trends highlight the importance of how the rising prevalence of heart disease is both generating political action and creating a significant tidal wave in demand for structured cardiac rehabilitation programmes to reduce mortality and enhance quality of life.

Is government support improving infrastructure for cardiac care delivery?

The infrastructure in the delivery of cardiac care is being improved greatly by government support, which has a direct positive impact on the cardiac rehabilitation market. An example is through the Ayushman Bharat programme; more than 1.6 lakh Health and Wellness Centres (HWCs) have been operationalised in India with emphasis on non-communicable diseases (NCDs) such as cardiovascular diseases (CVDs). As of 2024, the Ministry of Health and Family Welfare states that over 87 crores of hypertension and over 29 crores of diabetes screening have been done in this case, since these are two key risk factors leading to cardiac events.

The National Programme for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) facilitates infrastructural provisions at district and community health levels, which allow cardiac rehabilitation. Essential cardiac care units are also becoming increasingly available in public hospitals with the help of schemes such as PM-ABHIM, which seeks to reinforce health systems, particularly in underserved regions. These advances are indicative of the strong governmental interest in improving the long-term cardiac care outcomes.

Are reimbursement policies inconsistent across healthcare systems worldwide?

The reimbursement policies of cardiac rehabilitation (CR) are extremely uneven in the healthcare systems of different countries globally, which poses a significant obstacle to market penetration. In high-income nations like the U.S., where the CR is covered by care and the private insurance companies, reimbursement is usually not sufficient to meet the cost of the CR underutilisation. Research published by the United States National Library of Medicine established that CR participation is less than 30% among the eligible beneficiaries of Medicare, partly because of financial disincentives to providers. Conversely, low- and middle-income countries (LMICs) do not have formal reimbursement systems, and thus patients are forced to pay out-of-pocket, which critically curtails access.

The World Health Organisation records that more than 3/4 of deaths related to cardiovascular diseases are in the LMICs, even though only 8% of these nations provide any CR services. This funding gap greatly limits the accessibility and adoption of CR in other countries, as it has demonstrated its efficacy in decreasing hospital readmission and enhancing long-term outcomes. The importance of dealing with these anomalies is paramount to fair cardiovascular treatment.

Can telehealth expansion create new cardiac rehab delivery models?

telehealth is expanding, and it is giving rise to new models of cardiac rehabilitation (CR) provision, especially through the resolution of long-standing barriers in access and adherence. The participation rates are low in traditional face-to-face CR programmes, with the CDC reporting that in 2016, around 24% of the eligible Medicare beneficiaries took part in CR. Rural or underserved regions, and telehealth models, including home-based or hybrid CR, can greatly enhance participation. A 2022 study article in the Journal of the American Heart Association determined that home-based CR was equivalent to centre-based CR regarding their ability to enhance such outcomes as exercise capacity and quality of life.

The Veterans Health Administration has deployed remote cardiac rehab initiatives exhibiting high levels of patient satisfaction and similar results in comparison to their in-person care. Such models decrease travel burdens as well and allow for scheduling, which can enhance long-term compliance and minimise hospital readmissions. Overall, telehealth is not an addition but a possible revolution in the way cardiac rehab is provided.

Will personalized medicine improve cardiac rehab outcomes and engagement?

The growth of telehealth is developing new and promising models of providing cardiac rehabilitation (CR), especially in resolving the traditional problems of access and adherence. Conventional face-to-face CR programmes have low attendance, and the CDC has reported that as of 2016, only an estimated 24% of eligible Medicare beneficiaries were enrolled in CR. Such models as home-based or hybrid CR, which are included in the category of telehealth, can contribute greatly to participation, particularly in rural or underserved regions. In a 2022 study published in the Journal of the American Heart Association, home-based CR proved as effective as centre-based CR in terms of its ability to positively influence such outcomes as exercise capacity and quality of life.

Remote cardiac rehab programmes have been established by the Veterans Health Administration and have a high level of patient satisfaction and similar results to inpatient treatment. The models also lessen the travel burdens and facilitate flexible scheduling, which can enhance long-term compliance and decrease hospital readmission. Overall, telehealth is not a mere addition but a possible revolution in the method of cardiac rehab provision.

What are the key market segments in the Cardiac Rehabilitation industry?

Based on the Program type, the Cardiac Rehabilitation Market has been classified into Phase I, Phase II, and Phase III. The most important segment of the cardiac rehabilitation market is Phase II. This stage entails the outpatient, medically prescribed physical and educational programmes that the patients are subjected to once they have been discharged. It is essential in enhancing patient outcomes since it emphasises the efforts to adjust risk factors, physical activity, and lifestyle-based changes, which greatly decrease the risks of recurring cardiac incidents. The rigorous and highly regulated nature of the Phase II rehabilitation makes it the foundation of cardiac recovery, which is the most demanded and invested in in the market.

Based on the Therapy Type, the Cardiac Rehabilitation Market has been classified into Exercise Training, Nutritional Counseling, Psychological Interventions, Risk Factor Modification, Patient Education & Lifestyle Management, and Occupational Therapy. Exercise training is the most noticeable form of therapy in the cardiac rehabilitation market. It forms the fundamental part of cardiac rehab programmes, and it assists patients to enhance cardiovascular fitness, boost their heart performance, and alleviate the symptoms of fatigue and shortness of breath. Physical recovery is not the only benefit of exercise training since it is also highly effective in reducing the chances of future heart-related attacks by sustaining good blood flow and enhancing cardiac muscle power. Exercise training is the most common and widely used form of therapy in the cardiac rehabilitation facility because of its direct effect on patient outcome and the fact that it is more critical in the rehabilitation process.

Which regions are leading the Cardiac Rehabilitation market, and why?

An integrated mix of modern healthcare facilities, reimbursement policies, and high awareness levels in the North American cardiac rehabilitation market is dominant. The prevalence of cardiovascular diseases is high in the region, which is partially contributed to by lifestyle factors including sedentary lifestyles, obesity, and poor diet, leading to the high demand for rehabilitation programmes. The availability of large market players and research institutes helps to promote ongoing innovation and service delivery.

Cardiac rehab is actively supported by governments and private insurers in such countries as the U.S. and Canada in the form of coverage and policy programmes, which increase attendance rates. Further, increasing numbers of aged people and a focus on their preventive treatment only help to cement the dominance of North America in the sphere. The use of digital health technologies and tele-rehabilitation services increases access as well for remote patients. The combination of these forces forms a healthy ecosystem that will lead to a consistent increase in the cardiac rehabilitation market in the region.

The Asia Pacific cardiac rehabilitation market is leading because of the convergence of the three factors that are a growing prevalence of cardiovascular diseases, growing awareness of preventive healthcare, and developing healthcare infrastructures. There is an increase in heart conditions in countries such as China, India, and Japan due to the ageing population, urbanisation, and changes in lifestyles, like unhealthy diets and lack of activities.

Governments and non-government healthcare providers are spending a lot of money on cardiac care programmes, tele-rehabilitation platforms, and modern medical technologies. The area has a high number of patients and an expanding population of the middle classes that require quality healthcare services. These, coupled with the favourable policy changes and affordable treatment services, are driving the booming development in cardiac rehabilitation services in the Asia Pacific.

Further, access to and quality of care are improving due to greater cooperation between local governments and international healthcare organisations. The focus of early diagnosis and individualised rehabilitation strategies is also spurring superior patient results, which underline the leadership of the region in this market.

What does the competitive landscape of the Cardiac Rehabilitation market look like?

Key operating players in the Cardiac Rehabilitation Market are Smith & Nephew Plc, Stryker Corporation, Johnson & Johnson (Depuy Mitek), Arthrex, Inc., Conmed Corporation, Zimmer Biomet Holdings, Inc., Breg, Inc., Mueller Cardiac Rehabilitation, Inc., DJO Global, Inc., and Wright, Medical Group N.V.

Cardiac Rehabilitation Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Cardiac Rehabilitation industry?

• In July 2025, GMHBA launched the Healthier Heart at GMHBA program, a fully funded six-week digital cardiac rehab offered through Cardihab with nurse support. The program allowed eligible members recovering from a cardiac event to access rehab digitally. It aimed to improve recovery through convenient, tech-enabled care.
• In January 2024, the American College of Cardiology partnered with Lupin Digital Health to introduce the first Digital Therapeutics Certificate for cardiologists. This initiative supported those using Remote Cardiac Rehab and Digital Heart Failure Clinic solutions. The "Digital Pioneer" award recognized practitioners who adopted tech-driven cardiac care.

Report Coverage:

By Program Type

• Phase I
• Phase II
• Phase III

By Therapy Type

• Exercise Training
• Nutritional Counseling
• Psychological Interventions
• Risk Factor Modification
• Patient Education & Lifestyle Management
• Occupational Therapy

By Equipment Used

• Treadmills
• Elliptical Trainers
• Rowing Machines
• Stationary Bicycles
• Heart Rate Monitors
• Blood Pressure Monitors
• Wearable Devices & Remote Monitoring Tools
• Telemetry & ECG Devices

By Indication

• Myocardial Infarction
• Coronary Artery Disease (CAD)
• Heart Failure
• Angina
• Cardiomyopathy
• Coronary Artery Bypass Grafting (CABG)
• Heart Valve Surgery
• Heart Transplantation
• Others

By Delivery Model

• Center-based Programs
• Home-based Programs
• Tele-rehabilitation Programs
• Hybrid Models

By End User

• Hospitals & Cardiac Specialty Centers
• Ambulatory Surgical Centers (ASCs)
• Rehabilitation Centers
• Homecare Settings
• Fitness & Wellness Centers

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of the Middle East & Africa

List of Companies:

• Core Health & Fitness LLC
• LifeWatch AG
• The ScottCare Corporation
• Ball Dynamics International LLC
• Brunswick Corporation
• Ergoline GmbH
• GE Healthcare
• Halma plc
• Honeywell International Inc.
• Koninklijke Philips N.V.
• Mortara Instrument Inc.
• OMRON Corporation
• Patterson Companies Inc.
• Rehabtronics Inc.
• Schiller AG

Frequently Asked Questions (FAQs)